Targeting adhesion to the vascular niche to improve therapy for acute myeloid leukemia
Niche hijack by malignant cells is considered to be a prominent cause of disease relapse. Barbier and colleagues uncover (E)-selectin as a novel mediator of malignant cell survival and regeneration which, upon blockade, has the potential to significantly improve therapeutic outcomes.
Guardado en:
Autores principales: | Myriam L. R. Haltalli, Cristina Lo Celso |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7fb30f4555cf4ea288f251cabb681d85 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
por: Valerie Barbier, et al.
Publicado: (2020) -
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosis
por: Meike Farber, et al.
Publicado: (2021) -
Adhesion Molecules Involved in Stem Cell Niche Retention During Normal Haematopoiesis and in Acute Myeloid Leukaemia
por: Julien M. P. Grenier, et al.
Publicado: (2021) -
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia.
por: Carolyn Glass, et al.
Publicado: (2013) -
Circular RNAs in acute myeloid leukemia
por: Vijendra Singh, et al.
Publicado: (2021)